Literature DB >> 19667203

XIAP mediates NOD signaling via interaction with RIP2.

Andreas Krieg1, Ricardo G Correa, Jason B Garrison, Gaëlle Le Negrate, Kate Welsh, Ziwei Huang, Wolfram T Knoefel, John C Reed.   

Abstract

NOD1 and NOD2 are members of the NOD-like receptor (NLR) protein family that are involved in sensing the presence of pathogens and are a component of the innate immune system. Upon activation by specific bacterial peptides derived from peptidoglycans, NODs interact via a CARD-CARD interaction with the receptor-interacting protein kinase RIP2, an inducer of NF-kappaB activation. In this report, we show that NOD signaling is dependent on XIAP, a member of the inhibitor of apoptosis protein (IAP) family. Cells deficient in XIAP exhibit a marked reduction in NF-kappaB activation induced by microbial NOD ligands and by over-expression of NOD1 or NOD2. Moreover, we show that XIAP interacts with RIP2 via its BIR2 domain, which could be disrupted by XIAP antagonists SMAC and SMAC-mimicking compounds. Both NOD1 and NOD2 associated with XIAP in a RIP2-dependent manner, providing evidence that XIAP associates with the NOD signalosome. Taken together, our data suggest a role for XIAP in regulating innate immune responses by interacting with NOD1 and NOD2 through interaction with RIP2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19667203      PMCID: PMC2732880          DOI: 10.1073/pnas.0907131106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.

Authors:  Mathieu J M Bertrand; Snezana Milutinovic; Kathleen M Dickson; Wai Chi Ho; Alain Boudreault; Jon Durkin; John W Gillard; James B Jaquith; Stephen J Morris; Philip A Barker
Journal:  Mol Cell       Date:  2008-06-20       Impact factor: 17.970

2.  Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.

Authors:  M G Sanna; C S Duckett; B W Richter; C B Thompson; R J Ulevitch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

3.  XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs.

Authors:  Fiona L Scott; Jean-Bernard Denault; Stefan J Riedl; Hwain Shin; Martin Renatus; Guy S Salvesen
Journal:  EMBO J       Date:  2005-01-13       Impact factor: 11.598

4.  An RNA interference screen identifies Inhibitor of Apoptosis Protein 2 as a regulator of innate immune signalling in Drosophila.

Authors:  Viola Gesellchen; David Kuttenkeuler; Michael Steckel; Nadège Pelte; Michael Boutros
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

5.  Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB.

Authors:  N Inohara; T Koseki; L del Peso; Y Hu; C Yee; S Chen; R Carrio; J Merino; D Liu; J Ni; G Núñez
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

6.  Identification of CARDIAK, a RIP-like kinase that associates with caspase-1.

Authors:  M Thome; K Hofmann; K Burns; F Martinon; J L Bodmer; C Mattmann; J Tschopp
Journal:  Curr Biol       Date:  1998-07-16       Impact factor: 10.834

7.  IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.

Authors:  Mads Gyrd-Hansen; Maurice Darding; Maria Miasari; Massimo M Santoro; Lars Zender; Wen Xue; Tencho Tenev; Paula C A da Fonseca; Marketa Zvelebil; Janusz M Bujnicki; Scott Lowe; John Silke; Pascal Meier
Journal:  Nat Cell Biol       Date:  2008-10-19       Impact factor: 28.824

8.  RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase.

Authors:  J V McCarthy; J Ni; V M Dixit
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

9.  RIP2-beta: a novel alternative mRNA splice variant of the receptor interacting protein kinase RIP2.

Authors:  Andreas Krieg; Gaëlle Le Negrate; John C Reed
Journal:  Mol Immunol       Date:  2009-01-03       Impact factor: 4.407

10.  Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2.

Authors:  Mathieu J M Bertrand; Karine Doiron; Katherine Labbé; Robert G Korneluk; Philip A Barker; Maya Saleh
Journal:  Immunity       Date:  2009-05-21       Impact factor: 31.745

View more
  137 in total

1.  Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.

Authors:  Sebastian Zeissig; Britt-Sabina Petersen; Michal Tomczak; Espen Melum; Emilie Huc-Claustre; Stephanie K Dougan; Jon K Laerdahl; Björn Stade; Michael Forster; Stefan Schreiber; Dascha Weir; Alan M Leichtner; Andre Franke; Richard S Blumberg
Journal:  Gut       Date:  2014-11-03       Impact factor: 23.059

2.  IAPs, TNF, inflammation and Jürg Tschopp; a personal perspective.

Authors:  J Silke; J E Vince
Journal:  Cell Death Differ       Date:  2012-01       Impact factor: 15.828

Review 3.  Non-apoptotic functions of apoptosis-regulatory proteins.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Christina Trojel-Hansen; Guido Kroemer
Journal:  EMBO Rep       Date:  2012-04-02       Impact factor: 8.807

Review 4.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 5.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

6.  ARTS and Siah collaborate in a pathway for XIAP degradation.

Authors:  Jason B Garrison; Ricardo G Correa; Motti Gerlic; Kenneth W Yip; Andreas Krieg; Craig M Tamble; Ranxin Shi; Kate Welsh; Srinivas Duggineni; Ziwei Huang; Keqin Ren; Chunying Du; John C Reed
Journal:  Mol Cell       Date:  2010-12-23       Impact factor: 17.970

7.  Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease.

Authors:  Steven M Chirieleison; Rebecca A Marsh; Prathna Kumar; Joseph K Rathkey; George R Dubyak; Derek W Abbott
Journal:  J Biol Chem       Date:  2017-04-12       Impact factor: 5.157

8.  Risk-factors Associated With Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review.

Authors:  Asama Lekbua; Jodie Ouahed; Amy E O'Connell; Stacy A Kahn; Jeffrey D Goldsmith; Toshihiko Imamura; Christine N Duncan; Judith R Kelsen; Elizabeth Worthey; Scott B Snapper; Samir Softic
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-07       Impact factor: 2.839

Review 9.  NOD proteins: regulators of inflammation in health and disease.

Authors:  Dana J Philpott; Matthew T Sorbara; Susan J Robertson; Kenneth Croitoru; Stephen E Girardin
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

10.  NLR functions beyond pathogen recognition.

Authors:  Thomas A Kufer; Philippe J Sansonetti
Journal:  Nat Immunol       Date:  2011-02       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.